HOME >> BIOLOGY >> NEWS
Clemson Researchers Turn Crabshells Into New Product Lines

McCLELLANVILLE D Clemson University researchers have developed a new process to turn crab shells into natural marketable products. Food and packaging scientists Ronald L. Thomas and Robert F. Testin at Clemson are working with W.E. (Eddie) Gordon, owner of the South Carolina Crab Company in McClellanville, to process crab shells into promising new product lines.

"Ninety percent of the shellfish is discarded in traditional seafood processing operations around the world," Thomas said. "We've developed a process to completely eliminate that and use 100 percent of the product."

The process is a closed-loop system that extracts the remainder of food-grade meat from the shells, then reduces the shells to their primary materials D chitin and calcium D with no discharge into the environment. The chitin can then be converted into chitosan and glucosamine, products that are in high demand by the food supplement industry, the medical profession, manufacturing and agriculture.

The food supplement, or nutraceutical industry, sells glucosamine as a treatment for chronic arthritis and chitosan as a natural fiber for reducing cholesterol and absorbing fat. Physicians use chitosan film as an "artificial skin" to treat burns and severe wounds because of its antimicrobial properties. Manufacturers use chitosan as a natural polymer to remove heavy metals from industrial waste water. Agriculture uses chitosan as a feed supplement for hogs and as a seed coating. The cosmetic industry uses it in shampoos and face creams.

"Chitin is the second most abundant natural polymer in the world after cellulose," Thomas said. "We're just beginning to explore all its possible applications."

Gordon's South Carolina Crab Company is developing a prototype system to process food-grade chitin, calcium and crab meat from the shells. The system is currently undergoing testing and refinements, with the possibility of commercial application t
'"/>

Contact: Ron Thomas
rthms@clemson.edu
864-656-5697
Clemson University
18-Dec-1998


Page: 1 2

Related biology news :

1. Clemson University spin-off uses corn to make plastics, provide cleaner air
2. Clemson researcher places hope on pushy photons
3. Clemson researcher receives Komen grant
4. Clemson University researcher reaches for the stars to prevent osteoporosis
5. Clemson launches S.C. DNA Learning Center
6. Clemson dedicates biotech research complex
7. Breakthrough Clemson research appears in Science
8. Clemson researcher takes part in breakthrough research on insects
9. Clemson researchers find bacteria fighter that does not promote bacterial resistance
10. Clemson researchers identify mental retardation gene
11. Clemson researchers create biosensors to protect nations food and water supplies

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Clemson Researchers Turn Crabshells Into New Product Lines

(Date:7/24/2014)... -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") announced the ... Phase 3 study of Zerenex (ferric citrate), the Company,s ... of hyperphosphatemia in patients with end-stage renal disease (ESRD) ... delivery with FErric CiTrate in EsrD) was published online ... of Nephrology ( JASN ). , ...
(Date:7/24/2014)... has different effects on different species of fish, ... of Bristol and Exeter which tested fish anti-predator ... a flying seagull predator model when exposed to ... European minnows. , Lead author Dr Irene ... "Noise levels in many aquatic environments have increased ...
(Date:7/24/2014)... own microbial terroir, meaning the microbial populations found on ... product, creating the final flavor according to research published ... Environmental Microbiology . This is the first time investigators ... , Many sake makers inoculate with both bacteria ... the University of California, Davis, but he and his ...
Breaking Biology News(10 mins):Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 4The microbes make the sake brewery 2
(Date:7/24/2014)... to settle into equilibriuma state of unchanging balance ... of non-equilibrium conditions where new possibilities lie. Non-equilibrium ... such as temperature fluctuations, freezing and melting, or ... body temperature, airplanes to fly, and the Earth ... even though these conditions exist naturally and are ...
(Date:7/24/2014)... Research and Markets has announced ... Analytical Instruments Market 2014-2018" report to their offering. ... Genomics is the study of the gene and its ... and functions of proteomes or sets of proteins by ... involves the mapping of genes and DNA sequencing to ...
(Date:7/24/2014)... 2014 SRI International has been awarded a ... of Allergy and Infectious Diseases (NIAID), part of the ... potential therapies for HIV infection and AIDS. The contract ... AIDS and the complications and opportunistic infections associated with ... transmission of HIV. According to the ...
(Date:7/24/2014)... 2014 Three companies from the angelMD ... Big C Competition. Out of 700 competition entrants, Chiron ... the semi-final round. In this round twenty teams are ... complete with mentoring from thought-leaders and medical entrepreneurs from ... the angelMD commitment to the Livestrong vision around the ...
Breaking Biology Technology:New approach to form non-equilibrium structures 2Global Genomics and Proteomics Analytical Instruments Market 2014-2018: Key Vendors are Agilent, Bio-Rad , F. Hoffmann, La Roche, Illumina, PerkinElmer and Thermo Fisher Scientific 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 33 angelMD Startups Make Livestrong Big C Semi-finals 2
Cached News: